Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy
- PMID: 26487971
- PMCID: PMC4607823
- DOI: 10.7497/j.issn.2095-3941.2015.0055
Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy
Abstract
[This corrects the article on p. 87 in vol. 12, PMID: 26175924.].
Erratum for
-
Assays for predicting and monitoring responses to lung cancer immunotherapy.Cancer Biol Med. 2015 Jun;12(2):87-95. doi: 10.7497/j.issn.2095-3941.2015.0019. Cancer Biol Med. 2015. PMID: 26175924 Free PMC article. Review.
References
-
- Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 2015;372:2018-2028. - PubMed
Publication types
LinkOut - more resources
Full Text Sources